Application Note: WB: 0.03-0.1μg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 19
Positive Control: The peptide used to generate this antibody is available for purchase (GTX89453-PEP).
Specificity/Sensitivity: This antibody is expected to recognise isoform 1 (NP_079088.1) only.
Form: Liquid
Buffer (with preservative): TBS, 0.5% BSA, 0.02% Sodium azide.
Concentration: 0.50 mg/ml (Please refer to the vial label for the specific concentration.)
Background: This gene was identified by gene expression studies in patients with acute myeloid leukemia (AML). The gene is conserved among mammals and is not found in lower organisms. Tissues that express this gene develop from the neuroectoderm. Multiple alternatively spliced transcript variants that encode different proteins have been described for this gene; however, some of the transcript variants are found only in AML cell lines. [provided by RefSeq, Jul 2008]
Uniprot ID: Q8WXS3
Antigen Species: Human
Immunogen: Peptide with sequence C-KQNGLQTTEAKRDAK, from the internal region of the protein sequence according to NP_079088.1.
Purification: Purified by ammonium sulphate precipitation followed by antigen affinity chromatography
Conjugation: Unconjugated
Full Name: BAALC binder of MAP3K1 and KLF4
Deutsch
English
